valsartan has been researched along with Shock, Cardiogenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YH; Lai, HC; Lee, WL; Liu, TJ | 1 |
| Li, GP; Li, LF; Liang, YZ; Liu, T; Qi, WW; Xu, G; Ye, L | 1 |
1 trial(s) available for valsartan and Shock, Cardiogenic
| Article | Year |
|---|---|
Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Atrial Fibrillation; Blood Pressure; China; Clinical Protocols; Electrocardiography, Ambulatory; Fatty Acids, Monounsaturated; Fluvastatin; Heart Failure; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Indoles; Myocardial Infarction; Prospective Studies; Recurrence; Research Design; Risk Assessment; Risk Factors; Shock, Cardiogenic; Time Factors; Treatment Outcome; Valsartan | 2015 |
1 other study(ies) available for valsartan and Shock, Cardiogenic
| Article | Year |
|---|---|
Iatrogenic Takotsubo Cardiomyopathy Following Overdose Norepinephrine Administration During Percutaneous Coronary Intervention.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Bisoprolol; Coronary Restenosis; Creatine Kinase; Creatine Kinase, MB Form; Drug Overdose; Drug-Eluting Stents; Echocardiography; Humans; Hypotension; Iatrogenic Disease; Intra-Aortic Balloon Pumping; Intraoperative Complications; Male; Medication Errors; Middle Aged; Norepinephrine; Percutaneous Coronary Intervention; Recovery of Function; Shock, Cardiogenic; Stents; Stroke Volume; Takotsubo Cardiomyopathy; Troponin I; Valsartan; Vasoconstrictor Agents | 2020 |